Altimmune, Inc. — Director's Dealing 2010

Oct 22, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2010-10-20

Reporting Person: RICHMAN ERIC I (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-20	Option to purchase	$4.20	A	125000	Acquired	2020-10-20	Common Stock (125000)	Direct

Footnotes

F1: The option vests 25% per year beginning on the first anniversary on the date of grant. Does not include an option to
purchase an additional 125,000 shares that accrues on a future date upon the occurrence of an event not under the control of
the grantee.

F2: The closing price of the Issuer's common stock on the NYSE Amex on October 20, 2010, the date the option was granted, was
$4.20.